Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Weissman NJ, Fearnot NE, Park SW, Park SJ; ASian Paclitaxel-Eluting Stent Clinical Trial. Hong MK, et al. Among authors: weissman nj. Circulation. 2003 Feb 4;107(4):517-20. doi: 10.1161/01.cir.0000054163.42072.d4. Circulation. 2003. PMID: 12566359 Clinical Trial.
A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. Park SJ, et al. Among authors: weissman nj. N Engl J Med. 2003 Apr 17;348(16):1537-45. doi: 10.1056/NEJMoa021007. N Engl J Med. 2003. PMID: 12700373 Free article. Clinical Trial.
Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Among authors: weissman nj. Am J Cardiol. 2005 Jan 1;95(1):105-7. doi: 10.1016/j.amjcard.2004.08.071. Am J Cardiol. 2005. PMID: 15619403 Clinical Trial.
Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Among authors: weissman nj. Am J Cardiol. 2005 Jan 1;95(1):107-9. doi: 10.1016/j.amjcard.2004.08.072. Am J Cardiol. 2005. PMID: 15619404 Clinical Trial.
Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ. Park DW, et al. Among authors: weissman nj. J Am Coll Cardiol. 2006 Dec 19;48(12):2432-9. doi: 10.1016/j.jacc.2006.08.033. Epub 2006 Nov 28. J Am Coll Cardiol. 2006. PMID: 17174179 Free article. Clinical Trial.
Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).
Mintz GS, Tinana A, Hong MK, Lee CW, Kim JJ, Fearnot NE, Park SW, Park SJ, Weissman NJ. Mintz GS, et al. Among authors: weissman nj. Circulation. 2003 Sep 16;108(11):1295-8. doi: 10.1161/01.CIR.0000091254.73351.D6. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952833 Clinical Trial.
361 results